Multipele endocriene neoplasie type 2 (MEN2)

PATIENT MATERIALS

English

Multiple endocrine neoplasia type 2 (MEN2) is characterised by the occurrence of medullary thyroid carcinoma, pheochromocytoma and, in one variant, primary hyperparathyroidism.The clinical manifestations of MEN2 are related to the syndrome subtypes and depend on the specific mutation in the RET gene. MEN2 can affect all age groups, with manifestations beginning in infancy to early childhood (MEN2B) or adulthood.

Nederlands

Multipele endocriene neoplasie type 2 (MEN2) wordt gekenmerkt door het optreden van medullair schildkliercarcinoom, feochromocytoom en, in een variant, primaire hyperparathyreoïdie. De klinische manifestaties van MEN2 zijn gerelateerd aan de subtypes van het syndroom en hangen af van de specifieke mutatie in het RET-gen. MEN2 kan alle leeftijdsgroepen treffen, met manifestaties die beginnen in de kindertijd tot vroege jeugd (MEN2B) of op volwassen leeftijd.

Note: Resource summaries and translations into relevant languages were produced with the assistance of ChatGPT.

Multiple Endocrine Neoplasia Type 2 ORPHAcode:653


* The information on this website is for general information only and does not replace medical advice from your doctor or healthcare professional. Always discuss your personal situation with your treating healthcare team. Healthcare systems and medical practice may differ between countries, so some information may not apply to your country. Copyright of third-party documents is respected. We are not responsible for the content of external websites linked from this site.